by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersJing Cheong Asia Inc. dba New York Tong Ren Tang

All Warning Letters

Jing Cheong Asia Inc. dba New York Tong Ren Tang

Warning LetterOpen

Jing Cheong Asia Inc. dba New York Tong Ren Tang, 4034 Main Street Flushing , NY 11354 United StatesIssued Oct 26, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateOct 26, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Jing Cheong Asia Inc. dba New York Tong Ren Tang
Location: Jing Cheong Asia Inc. dba New York Tong Ren Tang, 4034 Main Street Flushing , NY 11354 United States
FEI Number: N/A
Country: United States
Issue Date: October 26, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

Unapproved New Drugs/Misbranded

Jing Cheong Asia Inc. dba New York Tong Ren Tang FDA Warning Letter, October 26, 2026